Bundeswehr Institute of Pharmacology and Toxicology (InstPharmToxBw), Neuherbergstr. 11, 80937, Munich, Germany.
Department of Chemistry, Humboldt-Universität zu Berlin, Brook-Taylor-Strasse 2, 12489, Berlin, Germany.
Arch Toxicol. 2019 Jul;93(7):1881-1891. doi: 10.1007/s00204-019-02461-2. Epub 2019 May 8.
We present the forensic analyses of plasma samples of human victims exposed to sulfur mustard (SM) in a crisis region in the Middle East in 2015. A few hours after exposure, poisoned persons showed typical signs and symptoms of percutaneous SM exposure including erythema and later on blisters and hardly healing skin wounds. Blood samples were collected 15 days after poisoning to be analyzed for the presence of long-lived protein-adduct biomarkers to verify SM poisoning. We applied a novel bioanalytical toolbox targeting four human serum albumin-derived biomarkers that were made accessible after plasma proteolysis. These adducts contained the SM-specific hydroxyethylthioethyl moiety either bound to the thiol group of a cysteine residue (C*) or to the side-chain carboxylic group of a glutamic acid residue (E*). Peptide biomarkers were produced from plasma of the victims using proteinase K (CPF), pronase (CP) and pepsin (AEVSKL and LQQCPFEDHVKL) for enzymatic protein cleavage. Separation and detection were carried out by selective micro-liquid chromatography-electrospray ionization high-resolution tandem mass spectrometry (µLC-ESI MS/HR MS). In addition to this site-specific adduct detection, a general approach after alkaline hydrolysis of the plasma protein fraction was applied. Liberated thiodiglycol (TDG) was derivatized with heptafluorobutyric anhydride and detected by gas chromatography-electron ionization mass spectrometry (GC-EI MS). The different bioanalytical methods yielded congruent results confirming SM poisoning for all patients who showed clinical signs and symptoms. This is the first time that real cases of SM poisoning were confirmed and presented by such a broad compilation of protein-derived biomarkers.
我们呈现了 2015 年在中东危机地区暴露于芥子气(SM)的人体受害者的血浆样本的法医分析。在暴露后的几个小时内,中毒者表现出典型的经皮 SM 暴露迹象和症状,包括红斑,随后出现水疱,皮肤伤口难以愈合。在中毒后 15 天采集血液样本,以分析存在长寿命蛋白加合物生物标志物来验证 SM 中毒。我们应用了一种针对四个人血清白蛋白衍生的生物标志物的新型生物分析工具盒,这些生物标志物在血浆蛋白水解后变得可及。这些加合物含有 SM 特异性的羟乙基硫乙基部分,要么与半胱氨酸残基的巯基(C*)结合,要么与谷氨酸残基的侧链羧酸基(E*)结合。使用蛋白酶 K(CPF)、蛋白酶(CP)和胃蛋白酶(AEVSKL 和 LQQCPFEDHVKL)从受害者的血浆中产生肽生物标志物,用于酶切蛋白。通过选择性微液相色谱-电喷雾电离高分辨串联质谱(µLC-ESI MS/HR MS)进行分离和检测。除了这种针对特定部位加合物的检测之外,还应用了一种碱性水解血浆蛋白部分后的一般方法。释放的硫代二甘醇(TDG)与七氟丁酰酐衍生化,并通过气相色谱-电子电离质谱(GC-EI MS)检测。不同的生物分析方法得出了一致的结果,证实所有出现临床症状和体征的患者均受到 SM 中毒。这是首次通过如此广泛的蛋白质衍生生物标志物组合确认和呈现 SM 中毒的真实案例。